Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac and Ranibizumab in Wet Macular Degeneration
NCT02060604Phase 4Completed
- Sponsor
- University of Brescia
- Start
- Dec 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketorolac in neovascular age-related macular degeneration (nAMD), sponsored by University of Brescia. Started Dec 2012; status: completed.
02
Drugs
ketorolac
03
Conditions
neovascular age-related macular degeneration (nAMD)
Beyond the preview
Go deeper on NCT02060604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02060604.